News | March 09, 2009

Assessing In-Stent Restenosis Can be Done by Dual-Source Computed Tomography


March 9, 2009 - The use of dual-source computed tomography (DSCT) may be useful to noninvasively detect in-stent restenosis, especially in stents with a relatively large diameter, according to a study in this week’s issue of the American Journal of Cardiology (pages 812-817).

The study was conducted by researchers from the Department of Internal Medicine, University of Erlangen-Nuremberg, Erlangen, Germany, the Institute of Diagnostic Radiology, University of Erlangen-Nuremberg, Erlangen, Germany, and the Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston. The assessed the accuracy of evaluating coronary artery stents using DSCT, because it provides higher temporal resolution that may allow more accurate evaluation of coronary stents. A total of 112 patients with 150 previously implanted coronary stents (diameter ?3 mm) were examined using a Definition DSCT made by Siemens Medical Solutions before conventional coronary angiography.

Each stent was classified as assessable or not assessable. All assessable stents were further classified for the absence or presence of in-stent restenosis (>50% diameter reduction) using DSCT, and results were compared with those using quantitative coronary angiography. Mean stent diameter was 3.27 ± 0.35 mm. Fifteen of 80 stents (19%) with a diameter of 3.0 mm were not assessable, and all 70 stents >3.0 mm were assessable. DSCT correctly identified 16 of 19 in-stent restenoses in 135 assessable stents, as well as the absence of in-stent restenosis in 110 of 116 stents (sensitivity 84%, specificity 95%, positive predictive value 73%, and negative predictive value 97% in assessable stents).

For more information: www.ajconline.org/article/S0002-9149%2808%2902091-2/abstract


Related Content

News | CT Angiography (CTA)

Oct. 27, 2025 — At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting in San Francisco, Royal ...

Home October 30, 2025
Home
News | CT Angiography (CTA)

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...

Home October 29, 2025
Home
News | CT Angiography (CTA)

Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA). The ...

Home October 23, 2025
Home
News | CT Angiography (CTA)

Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 09, 2025
Home
News | CT Angiography (CTA)

Aug. 11, 2025 — Elucid announced that United Healthcare has updated its cardiac imaging guidelines to align with recent ...

Home August 11, 2025
Home
News | CT Angiography (CTA)

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Home May 02, 2025
Home
News | CT Angiography (CTA)

May 1, 2025 — A new expert opinion document jointly released by the Society for Cardiovascular Angiography and ...

Home May 01, 2025
Home
Feature | CT Angiography (CTA) | By Melinda Taschetta-Millane

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and ...

Home March 07, 2024
Home
News | CT Angiography (CTA)

January 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions ...

Home January 23, 2024
Home
News | CT Angiography (CTA)

January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with ...

Home January 11, 2024
Home
Subscribe Now